Journal Club
1. Spectrum Of Pulmonary Fungal Pathogens And Antifungal Drug Susceptibility Among TB Relapse And Retreatment Samples At Selected Health Facilities In Kenya - PhD Research Update
0
IAVI-W001 Study Launched at the KAVI-Institute of Clinical Research
On 24th September 2019, the first volunteer was enrolled in the IAVI-W001 study at the KAVI-Institute of Clinical Research (KAVI-ICR) of the University of Nairobi. The occasion marks the beginning of the 12th HIV vaccine clinical trial to be conducted at KAVI-ICR since 2001. This is a first-in-human study that uses a Native-trimer HIV envelope design that will hopefully stimulate broadly neutralizing antibodies against HIV.
0
Prof. Omu Anzala leads the national task force’s research pillar, supporting evidence generation to inform the response.
KAVI-Institute of Clinical Research at the University of Nairobi is contributing research expertise to Kenya’s Ebola response, with Senior Scientist Prof. Omu Anzala co-leading the research pillar of the national Ebola task force. The pillar brings together multidisciplinary expertise to identify research priorities and generate evidence to inform the national response.